Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives
Open Access
- 15 June 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Death Discovery
- Vol. 6 (1), 1-12
- https://doi.org/10.1038/s41420-020-0286-z
Abstract
Drug induced resistance is a widespread problem in the clinical management of cancer. Cancer cells, when exposed to cytotoxic drugs, can reprogram their cellular machinery and resist cell death. Evasion of cell death mechanisms, such as apoptosis and necroptosis, are part of a transcriptional reprogramming that cancer cells utilize to mediate cytotoxic threats. An additional strategy adopted by cancer cells to resist cell death is to initiate the epithelial to mesenchymal transition (EMT) program. EMT is a trans-differentiation process which facilitates a motile phenotype in cancer cells which can be induced when cells are challenged by specific classes of cytotoxic drugs. Induction of EMT in malignant cells also results in drug resistance. In this setting, therapy-induced senescence (TIS), an enduring “proliferative arrest”, serves as an alternate approach against cancer because cancer cells remain susceptible to induced senescence. The molecular processes of senescence have proved challenging to understand. Senescence has previously been described solely as a tumor-suppressive mechanism; however, recent evidences suggest that senescence-associated secretory phenotype (SASP) can contribute to tumor progression. SASP has also been identified to contribute to EMT induction. Even though the causes of senescence and EMT induction can be wholly different from each other, a functional link between EMT and senescence is still obscure. In this review, we summarize the evidence of potential cross-talk between EMT and senescence while highlighting some of the most commonly identified molecular players. This review will shed light on these two intertwined and highly conserved cellular process, while providing background of the therapeutic implications of these processes.Keywords
This publication has 122 references indexed in Scilit:
- A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic AdenocarcinomaACS Chemical Biology, 2012
- Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast CancerOnline Journal of Public Health Informatics, 2012
- Cellular senescence and tumor suppressor gene p16International Journal of Cancer, 2011
- p53 regulation by ubiquitinFEBS Letters, 2011
- Four faces of cellular senescenceThe Journal of cell biology, 2011
- Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joiningNature Structural & Molecular Biology, 2010
- Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular SenescenceCancer Cell, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathwayFree Radical Biology & Medicine, 2007